ProShare Advisors LLC Purchases 13,273 Shares of Agilent Technologies, Inc. $A

ProShare Advisors LLC grew its position in Agilent Technologies, Inc. (NYSE:A) by 28.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 60,084 shares of the medical research company’s stock after buying an additional 13,273 shares during the period. ProShare Advisors LLC’s holdings in Agilent Technologies were worth $10,353,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. State Street Corp grew its holdings in shares of Agilent Technologies by 0.7% during the second quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock valued at $1,710,658,000 after buying an additional 89,598 shares during the last quarter. Wellington Management Group LLP increased its position in shares of Agilent Technologies by 2.7% during the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after acquiring an additional 198,253 shares in the last quarter. Deutsche Bank AG increased its position in shares of Agilent Technologies by 17.1% during the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after acquiring an additional 1,024,516 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of Agilent Technologies by 87.4% during the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after acquiring an additional 2,440,360 shares in the last quarter. Finally, Legal & General Group Plc purchased a new position in Agilent Technologies in the 2nd quarter worth approximately $260,101,000.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on A. Weiss Ratings raised Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Royal Bank Of Canada increased their target price on Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Robert W. Baird lifted their target price on Agilent Technologies from $180.00 to $195.00 and gave the stock an “outperform” rating in a report on Thursday, October 8th. Piper Sandler boosted their price target on Agilent Technologies from $150.00 to $160.00 and gave the stock a “neutral” rating in a research note on Friday, August 28th. Finally, Sanford C. Bernstein boosted their price target on Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Eighteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $181.45.

Insider Buying and Selling

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $175.73 on Wednesday. The firm’s 50-day moving average price is $164.81 and its 200-day moving average price is $136.68. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The company has a market cap of $49.54 billion, a PE ratio of 34.59, a PEG ratio of 2.52 and a beta of 1.24. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $182.99.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same period in the previous year, the business posted $1.37 earnings per share. The business’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were issued a $0.2550 dividend. The ex-dividend date was Tuesday, October 6th. This represents a $1.02 annualized dividend and a yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.